You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD133

Showing 1 - 25 of 1,010
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myocardial Ischemia Trial in Monza, Milano, Torino (Autologous bone marrow derived-CD133+ cells)

Completed
  • Chronic Myocardial Ischemia
  • Autologous bone marrow derived-CD133+ cells
  • Monza, MB, Italy
  • +2 more
Mar 21, 2022

Colorectal Cancer Trial in Madrid (CD133+ infusion, portal vein embolization)

Completed
  • Colorectal Cancer
  • CD133+ infusion
  • portal vein embolization
  • Madrid, Spain
  • +1 more
Sep 22, 2021

Heart Failure Trial in Hamburg (autologous CD133pos stem cell application)

Terminated
  • Heart Failure
  • autologous CD133pos stem cell application
  • Hamburg, Germany
    ASKLEPIOS Klinik St. Georg
Aug 20, 2021

CD133 Expression in Mammary Invasive Ductal Carcinoma

Recruiting
  • Breast Cancer
    • Sohag, Egypt
    • +1 more
    May 5, 2021

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Chronic Ischemic Heart Disease Trial in Lexington (Bone Marrow Derived Autologous CD133+ Selected Cell Product)

    Completed
    • Chronic Ischemic Heart Disease
    • Bone Marrow Derived Autologous CD133+ Selected Cell Product
    • Lexington, Kentucky
      University of Kentucky Healthcare
    Dec 9, 2020

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    End Stage Liver Disease Trial in Singapore (GCSF, CD133 Cells Transplantation)

    Recruiting
    • End Stage Liver Disease
    • GCSF
    • CD133 Cells Transplantation
    • Singapore, Singapore
      National University Hospital
    Jan 14, 2021

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022

    Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Stage IV Cutaneous Melanoma AJCC v6 and v7
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Aldesleukin
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 15, 2021

    Coronary Artery Disease Trial in Jakarta (Transepicardial with Transseptal CD 133+ Implantation)

    Completed
    Has Results
    • Coronary Artery Disease
    • Transepicardial with Transseptal CD 133+ Implantation
    • Jakarta, DKI Jakarta, Indonesia
      National Cardiovascular Center Harapan Kita
    Mar 16, 2020

    HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston

    Active, not recruiting
    • HLA-A*0201 Positive Cells Present
    • +3 more
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Retinitis Pigmentosa Trial in Amman (Stem Cell Transplantation)

    Unknown status
    • Retinitis Pigmentosa
    • Stem Cell Transplantation
    • Amman, Jordan
      Stem Cells Arabia
    Mar 15, 2020

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +14 more
    • Aldesleukin
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Spinal Cord Injury Trial in Amman (Stem Cell Transplantation)

    Unknown status
    • Spinal Cord Injury
    • Stem Cell Transplantation
    • Amman, Jordan
      Stem Cells Arabia
    Mar 15, 2020

    Myocardial Ischemia, Coronary Artery Disease Trial in Germany (CD133+ autologous bone marrow stem cell, Placebo)

    Terminated
    • Myocardial Ischemia
    • Coronary Artery Disease
    • CD133+ autologous bone marrow stem cell
    • Placebo
    • Bad Oeynhausen, Germany
    • +5 more
    Jul 13, 2020

    Liver Cancer, Pancreatic Cancer, Brain Tumor Trial in Beijing (anti-CD133-CAR vector-transduced T cells)

    Completed
    • Liver Cancer
    • +6 more
    • anti-CD133-CAR vector-transduced T cells
    • Beijing, Beijing, China
      Biotherapeutic Department and Pediatrics Department of Chinese P
    Dec 15, 2019

    Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

    Terminated
    Has Results
    • Advanced Pleural Malignant Mesothelioma
    • +10 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2021

    Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

    Completed
    • Metastatic Pancreatic Adenocarcinoma
    • +3 more
    • Aldesleukin
    • +9 more
    • Detroit, Michigan
      Wayne State University/Karmanos Cancer Institute
    Mar 30, 2022

    Acute Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Leukemia, Bilineage, Acute Trial in Baltimore (Ex vivo expansion of cord

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +3 more
    • Ex vivo expansion of cord blood
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Feb 14, 2020

    Neuroblastoma Trial in Houston (drug, procedure, device)

    Terminated
    Has Results
    • Neuroblastoma
    • Houston, Texas
      UT MD Anderson Cancer Center
    Jul 10, 2019

    Oral Squamous Cell Carcinoma, Neoadjuvant Chemo Trial in Jakarta Pusat (Melatonin 20 MG Oral Capsule, Placebo oral capsule)

    Completed
    Has Results
    • Oral Squamous Cell Carcinoma
    • Neoadjuvant Chemotherapy
    • Melatonin 20 MG Oral Capsule
    • Placebo oral capsule
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Faculty of Medicine, Universitas Indonesia
    Nov 20, 2019

    Asherman Syndrome Trial in Barcelona (CD133+ cells isolation)

    Unknown status
    • Asherman Syndrome
    • CD133+ cells isolation
    • Barcelona, Spain
      Hospital Vall D´Hebron
    Jul 16, 2019

    Non-obstructive Azoospermia Trial in Amman (Stem Cell Transplantation)

    Unknown status
    • Non-obstructive Azoospermia
    • Stem Cell Transplantation
    • Amman, Jordan
      Stem Cells of Arabia
    Mar 15, 2020